Brief: Karolinska Development Portfolio Co Secures Bridge Financing
Nov 20 (Reuters) - Karolinska Development AB KDEV.ST :
* SAID ON TUESDAY MODUS THERAPEUTICS SECURED BRIDGE
FINANCING OF
UP TO SEK 5 MLN FROM KAROLINSKA DEVELOPMENT
* FUNDING ENABLES MODUS TO INITIATE THE RECENTLY APPROVED
PHASE 2A
STUDY IN CHRONIC KIDNEY DISEASE
Source text for Workspace: urn:newsml:reuters.com:*:nGNE9kgNgJ
Further company coverage: KDEV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Modus Therapeutics Holding AB
See all newsBrief: Modus Therapeutics Temporarily Pauses Enrollment In Phase IIa Study Of Sevuparin In CKD With Anemia
Brief: Modus Gets SEK 0.13 Mln Through Exercise Of Warrants
Brief: Modus Therapeutics Resolves On Directed Share Issue Of 20 Million Shares
Sweden's Modus Therapeutics narrows Q2 net loss, extends financing
Brief: Modus Therapeutics Q2 Net Income SEK -4.645 Million